Analysis of the clinical efficacy of acupuncture combined with selective serotonin reuptake inhibitors (SSRIs) in the treatment depression
10.12206/j.issn.1006-0111.202006099
- VernacularTitle:针灸结合选择性5-羟色胺再摄取抑制剂治疗抑郁症的临床疗效分析
- Author:
Xiazhen LI
1
;
Weiwei SONG
1
;
Zhongli HE
1
Author Information
1. Department of Rehabilitation Medicine, No. 908 Hospital of Joint Logistics Support Force of PLA，Nanchang 330002，China.
- Keywords:
acupuncture;
SSRIs;
depression;
moxibustion;
clinical efficacy
- From:
Journal of Pharmaceutical Practice
2021;39(4):366-368
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical efficacy of acupuncture combined with SSRIs in the treatment of patients with depression. Methods A total of 83 patients with depression admitted to our hospital between January 2019 and January 2020 were selected as the research objects. Patients in the control group were treated with SSRIs, and the combined treatment (observation) group was treated with acupuncture on the basis of the control group. The clinical efficacy, anxiety (HAMD) and depression scale (HAMD) of patients in the two groups were compared. Results After treatment, the clinical efficacy of depression patients in the observation group was significantly higher than that in the control group (P<0.05). HAMA and HAMD scores showed statistical difference between the two groups. HAMA and HAMD scores of patients in the observation group were lower than those in the control group (P<0.05). Conclusion Acupuncture combined with SSRIs in the treatment of depression can significantly improve the patient's condition, reduce the patient's anxiety and depression, and has a positive significance for the treatment of the patients.
